The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorZheng Liu ENT

About this trial

Chronic rhinitis affects 10-40% of China's population, or over 300 million people, and can lead to respiratory and psychological issues. Despite treatment progress, 30% of patients have poor outcomes, likely due to the disease's complexity and a lack of new treatment targets. The incidence is rising, but there's a lack of nationwide studies on its variations. This study addresses this through a multicentric survey to create a national database on chronic rhinitis, including epidemiological, clinical, and biological data. The goal is to understand chronic rhinitis's causes and risks, improve treatments, and develop preventive strategies. The study will survey 30,000 patients across China, using questionnaires and nasal exams, and preserve biological samples in a biobank for detailed analysis. This will lay the groundwork for understanding the disease's mechanisms, developing new diagnostics, and tailoring prevention and treatment approaches for different forms of chronic rhinitis.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Epidemiological investigation

Treatment groups

150,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Zheng Liu ENT

Lead sponsor

Tongji Hospital

Sponsor institution

Peking Union Medical College

Collaborator

Hainan People's Hospital

Collaborator

Shandong Second Provincial General Hospital

Collaborator

First Affiliated Hospital of Chongqing Medical University

Collaborator

First Affiliated Hospital of Xinjiang Medical University

Collaborator